UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2020

 

Commission File Number: 001-36187

EVOGENE LTD.

  (Translation of Registrant’s Name into English)

 

13 Gad Feinstein Street

Park Rehovot P.O.B 2100

Rehovot 7612002 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒     Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

CONTENTS

 

Evogene Ltd., or the Company, reports changes in the management of one of its subsidiaries:

 

Mr. Eran Kosover, CEO of AgPlenus Ltd., or AgPlenus, Evogene’s wholly owned subsidiary focused on the development of ag-chemicals, requested to resign from his position, effective as of June 1, 2020.  Mr. Kosover will continue to serve AgPlenus as an active board member and as a consultant. Mr. Kosover’s resignation was not a result of a disagreement with the Company or AgPlenus on any matters related to the Company’s or AgPlenus’ operations, policies or practices. The Company is currently seeking a replacement for this position and will update accordingly.